Tennessee Medical Association Honors Two Doctors from the University of Tennessee Health Science Center with Outstanding Physician Awards

UT College of Medicine Alumnus Also Honored With Distinguished Service Award

Dr. James Eason

Dr. James Eason

James Eason, MD, FACS, professor and chief of the Division of Transplant Surgery in the College of Medicine at the University of Tennessee Health Science Center (UTHSC) and medical director of the Methodist University Hospital Transplant Institute, received an Outstanding Physician Award from the Tennessee Medical Association (TMA) at its recent annual convention in Nashville.

The TMA also honored J. Mack Worthington, MD, FAAFP, professor and chair of Family Medicine in the UTHSC College of Medicine, Chattanooga, with an Outstanding Physician Award. The award is given annually by the TMA House of Delegates to member physicians, who through their illustrious medical careers, make an impression among their colleagues, peers and on the profession of medicine. [Read more...]

Teresa Waters, Chair of Preventive Medicine, Receives $749,998 Grant to Study Medicare Penalties for Hospital Readmissions

A $749,998 grant from the Agency for Health Care Research and Quality will allow Dr. Teresa Waters, pictured with team members Dr. Cameron Kaplan (left) and Dr. Tao Li, to examine the effects of Medicare hospital readmission policies.

A $749,998 grant from the Agency for Health Care Research and Quality will allow Dr. Teresa Waters, pictured with team members Dr. Cameron Kaplan (left) and Dr. Tao Li, to examine the effects of Medicare hospital readmission policies.

Almost 20 percent of Medicare beneficiaries discharged from hospitals will be readmitted within 30 days, costing the Center for Medicare and Medicaid Services (CMS) almost $25 billion per year. [Read more...]

GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop SARD Drug Candidate to Treat Castration-Resistant Prostate Cancer

GTx, Inc. today announced that it has entered into an exclusive worldwide license agreement with the University of Tennessee Research Foundation (UTRF) to develop its proprietary selective androgen receptor degrader (SARD) technology which potentially can degrade and inhibit all forms of androgen receptor (AR), including those resistant to current therapies, to inhibit tumor growth in patients with progressive castration-resistant prostate cancer (CRPC). [Read more...]

Lori S. Gonzalez, PhD, Appointed Vice Chancellor of Academic, Faculty and Student Affairs at UTHSC

Lori S. Gonzalez, PhD

Lori S. Gonzalez, PhD

Steve J. Schwab, MD, chancellor at the University of Tennessee Health Science Center (UTHSC), has named Lori S. Gonzalez, PhD, vice chancellor of Academic, Faculty and Student Affairs. Dr. Gonzalez joins UTHSC from the University of North Carolina General Administration, the North Carolina higher education authority, where she served as special advisor to the chief academic officer. As the chief academic officer of UTHSC and its statewide campuses, Dr. Gonzalez will report directly to the chancellor. She is expected to assume her new responsibilities, working from UTHSC’s main campus in Memphis, on July 1. [Read more...]

Registration Opens for 13th ‘All Days Are Happy Days’ Summer Camp, Targeting Children with ADHD, Organized by UTHSC

Every year more than 11 million children and adults attend camp in the United States, according to the American Camping Association. For Memphis children who have been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), the UT Boling Center for Developmental Disabilities has opened registration for its 13th “All Days Are Happy Days” summer day camp. [Read more...]

Professor Byron Jones Awarded $2.6 Million to Study Toxicity of the Herbicide Paraquat on the Brain

 A $2.6 million grant from the National Institute of Environmental Health Sciences will allow Dr. Byron Jones and his collaborators to further investigate if Paraquat, a weed killer, poses risks for brain disorders such as Parkinson’s disease.

A $2.6 million grant from the National Institute of Environmental Health Sciences will allow Dr. Byron Jones and his collaborators to further investigate if Paraquat, a weed killer, poses risks for brain disorders such as Parkinson’s disease.

Paraquat is a weed killer used extensively in agriculture in the United States and other parts of the world. It is suspected to increase risk for developing Parkinson’s disease.
Byron Jones, PhD, and his research team are using newly awarded funds to investigate individual toxicity to the chemical on certain areas of the brain.

Dr. Jonesa professor in the Department of Genetics, Genomics and Informatics in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has received a grant totaling $2.6 million from the National Institute of Environmental Health Sciences, a subsidiary of the National Institutes of Health. [Read more...]

Social Workers Ashley Annestedt and Malissa Duckworth of UTHSC to Lead 2015 Conference for the Association for Successful Parenting

Social workers Ashley Annestedt (left) and Malissa Duckworth (right)  have been asked to lead the 2015 A Chance to Parent Conference, hosted by The Association for Successful Parenting. The theme of the conference being held in Memphis is “Promoting Change Through Advocacy, Policy and Practice.”

Social workers Ashley Annestedt (left) and Malissa Duckworth (right) have been asked to lead the 2015 A Chance to Parent Conference, hosted by The Association for Successful Parenting. The theme of the conference being held in Memphis is “Promoting Change Through Advocacy, Policy and Practice.”

The Association for Successful Parenting (TASP) is hosting the seventh biannual A Chance to Parent Conference with this year’s theme, “Promoting Change Through Advocacy, Policy and Practice.” [Read more...]

John Bissler, MD, Receives $637,501 Grant for Renal Tumor Research

A $637,501 grant from the U.S. Army Medical Research Acquisition Activity will allow Dr. John Bissler and his research team to study prevention and treatment options for tuberous sclerosis complex.

A $637,501 grant from the U.S. Army Medical Research Acquisition Activity will allow Dr. John Bissler and his research team to study prevention and treatment options for tuberous sclerosis complex.

John Bissler, MD, and his research team study a disease in children and adults called tuberous sclerosis complex (TSC), which predisposes patients to an unusual type of renal tumors. The team aims to use a newly developed model to study whether anti-hypertension drugs already approved for use in children will prevent tumors and the disease.

Dr. Bissler, a professor in the Department of Pediatrics at the University of Tennessee Health Science Center (UTHSC), has received a grant totaling $637,501 from theU.S. Army Medical Research Acquisition Activity to study renal tumor treatment options. The award will be used to support a project titled, “Prevention of TSC Renal Disease,” and will be distributed over three years. [Read more...]